Insmed Incorporated
Insmed Incorporated (INSM) Stock Overview
Explore Insmed Incorporated’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
35.2B
P/E Ratio
-27.62
EPS (TTM)
$-6.18
ROE
-1.68%
INSM Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Insmed Incorporated (INSM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 58.34, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $221.64.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -27.62 and a market capitalization of 35.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.